Given Imaging Files For Public Offering
YOQNEAM, Isreal-Given Imaging Ltd., which made headlines recently with their new virtual colonoscopy equipment, has filed with the Securities and Exchange Commission for a proposed initial public offering of its ordinary shares.
The company wants to be listed on the Nasdaq National Market under the ticket symbol "GIVN."
The Given System is a proprietary wireless imaging system that represents a new method of virtual visual examination of the gastrointestinal tract. A miniaturized video camera contained in a capsule is ingested by the patient and delivers color images in a painless and noninvasive procedure.
For more information about the Given System or the company, log onto www.givenimaging.com.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
